Johannes Bargehr, Jorge F. Trejo‐Gutierrez, Tushar Patel, Barry Rosser, Jaime Aranda‐Michel, Maria L. Yataco, C. Burcin Taner – 8 December 2014 – Atrial fibrillation (AF) is the most common cardiac arrhythmia, and it is associated with increased cardiovascular morbidity and all‐cause mortality. Our aim was to determine the impact of preexisting AF on patients undergoing liver transplantation (LT). A retrospective case‐control study was performed. Records from patients who underwent LT between January 2005 and December 2008 at Mayo Clinic Florida were reviewed.

Andreia Carvalho, Ana Rocha, Luísa Lobato – 6 December 2014 – Hereditary transthyretin amyloidosis (ATTR) is a rare worldwide autosomal dominant disease caused by the systemic deposition of an amyloidogenic variant of transthyretin (TTR), which is usually derived from a single amino acid substitution in the TTR gene. More than 100 mutations have been described, with V30M being the most prevalent. Each variant has a different involvement, although peripheral neuropathy and cardiomyopathy are the most common.

Margaret Tejani, Soo Youn Yi, Kyle W. Eudailey, Isaac George, James V. Guarrera, Gebhard Wagener – 6 December 2014

Yeon Seok Seo, Chang Ho Jung, Tae Hyung Kim, Sun Young Yim, Soon Ho Um – 6 December 2014

Shirish Barve, Irina A. Kirpich, Craig. J. McClain – 6 December 2014

Giovanni Musso, Maurizio Cassader, Roberto Gambino – 6 December 2014

Won Hyeok Choe, Soon Koo Baik – 6 December 2014

Rohit Loomba, Claude B. Sirlin, Brandon Ang, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Linda Soaft, Jonathan Hooker, Yuko Kono, Archana Bhatt, Laura Hernandez, Phirum Nguyen, Mazen Noureddin, William Haufe, Catherine Hooker, Meng Yin, Richard Ehman, Grace Y. Lin, Mark A. Valasek, David A. Brenner, Lisa Richards, San Diego Integrated NAFLD Research Consortium (SINC) – 6 December 2014 – Ezetimibe inhibits intestinal cholesterol absorption and lowers low‐density lipoprotein cholesterol.

Allon Kahn, Elizabeth J. Carey, Janis E. Blair – 6 December 2014 – Recipients of liver transplantation (LT) are at increased risk for symptomatic coccidioidomycosis, primarily because of chronic immunosuppression and impaired cellular immunity. Unfortunately, no consensus exists regarding optimal posttransplant prophylaxis. In a prior study at our institution, we observed both de novo and recurrent coccidioidomycosis despite targeted antifungal prophylaxis.

Stefano Romeo, Paola Dongiovanni, Salvatore Petta, Jussi Pihalajamaki, Luca Valenti – 6 December 2014